Insider holders · CIK 0001638381
Intec Pharma Ltd. · NTEC
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Dexcel Pharma Technologies Ltd.10% Owner | 5,150,848 | — | 5,150,848 | Feb 14, 2019 · 8:52 am EST | Form 3 |
| Dan Oren10% Owner | 5,150,848 | — | 5,150,848 | Feb 14, 2019 · 8:52 am EST | Form 3 |
| Jeffrey A MecklerChief Executive Officer | 76,761 | — | 76,761 | Jan 2, 2019 · 5:12 pm EST | Form 3 |
| John W KozarichDirector | 51,761 | — | 51,761 | Jan 2, 2019 · 5:13 pm EST | Form 3 |
| Anthony J MaddalunaDirector | 28,570 | — | 28,570 | Jan 2, 2019 · 5:10 pm EST | Form 3 |
| Nadav NavonChief Operating Officer | 19,456 | — | 19,456 | Jan 2, 2019 · 5:13 pm EST | Form 3 |
| Gil BiancoDirector | 10,000 | — | 10,000 | Jan 2, 2019 · 5:11 pm EST | Form 3 |
| Issac SilbermanDirector | 5,000 | — | 5,000 | Jan 2, 2019 · 5:11 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.